<?xml version="1.0" encoding="UTF-8"?>
<ref id="B142-ijms-21-03474">
 <label>142.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Xu</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Sun</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Fu</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Zhou</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>X.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Effective treatment of severe COVID-19 patients with tocilizumab</article-title>
  <source>Proc. Natl. Acad. Sci. USA</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1073/pnas.2005615117</pub-id>
 </element-citation>
</ref>
